New York State Attorney General Letitia James has filed a petition to compel Tyson Foods to comply with a subpoena in connection with ongoing price gouging investigations by the state.  New York’s price gouging statute imposes civil penalties on sellers of essential goods charging unconscionably excessive prices during an abnormal disruption of the market.  The subpoena requests information relating to prices, dates of sale, purchasers, costs, and profit margin for Tyson’s meat products sold in New York from December 1, 2019 through April 2022.

In the petition, the NY AG alleges that Tyson partially complied with the subpoena, but later refused to provide additional information on the grounds that the company’s sales in New York were interstate sales during the relevant period, and thus not covered by New York’s price gouging law.  Tyson appears to be relying on a Dormant Commerce Clause argument against the application of New York’s price gouging law, a topic covered in a previous post.

Despite any defenses Tyson may raise, or ultimately succeed on, the petition and ongoing investigation serves as a warning to businesses that price gouging compliance continues to remain an area of focus for government regulators and enforcement agencies even two-and-a-half years after the start of the COVID-19 pandemic.  New York previously lifted its COVID-19 State of Emergency over a year ago, on June 24, 2021, however, on December 26, 2021, the Governor declared a second State of Emergency in reaction to the emergence of new COVID-19 variants.  The second State of Emergency remains in place, triggering New York’s price gouging law.

As we have previously discussed, price gouging laws historically are designed to temporarily prevent local price increases in reaction to emergencies such as severe storms, wildfires, flooding, etc.  Many states, and the federal government, continue to have active states of emergency related to the pandemic, triggering many states’ price gouging laws.  As market factors such as inflation, fuel costs, and supply chain issues, force reputable businesses to raise prices on goods and services, law-abiding business face the challenging scenario of navigating price gouging laws while costs continue to rise – requiring a redoubling of compliance efforts

*      *      *

Visit Proskauer on Price Gouging for antitrust insights on COVID-19.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of John R. Ingrassia John R. Ingrassia

John is a partner at the Firm, advising on the full range of foreign investment and antitrust matters across industries, including chemicals, pharmaceutical, medical devices, telecommunications, financial services consumer goods and health care. He is the first call clients make in matters relating…

John is a partner at the Firm, advising on the full range of foreign investment and antitrust matters across industries, including chemicals, pharmaceutical, medical devices, telecommunications, financial services consumer goods and health care. He is the first call clients make in matters relating to competition and antitrust, CFIUS or foreign investment issues.

For more than 25 years, John has counselled businesses facing the most challenging antitrust issues and helped them stay out of the crosshairs — whether its distribution, pricing, channel management, mergers, acquisitions, joint ventures, or price gouging compliance.

John’s practice focuses on the analysis and resolution of CFIUS and antitrust issues related to mergers, acquisitions, and joint ventures, and the analysis and assessment of pre-merger CFIUS and HSR notification requirements. He advises clients on issues related to CFIUS national security reviews, and on CFIUS submissions when non-U.S. buyers seek to acquire U.S. businesses that have national security sensitivities.  He also regularly advises clients on international antitrust issues arising in proposed acquisitions and joint ventures, including reportability under the EC Merger Regulation and numerous other foreign merger control regimes.

His knowledge, reputation and extensive experience with the legal, practical, and technical requirements of merger clearance make him a recognized authority on Hart-Scott-Rodino antitrust merger review. John is regularly invited to participate in Federal Trade Commission and bar association meetings and takes on the issues of the day.

Photo of Timothy E. Burroughs Timothy E. Burroughs

Tim Burroughs is an associate in the Litigation Department and a member of the Antitrust and Commercial Litigation groups. Tim’s practice focuses on assisting clients navigate a range of antitrust issues from investigations and litigation to compliance with pre-merger CFIUS and HSR notification…

Tim Burroughs is an associate in the Litigation Department and a member of the Antitrust and Commercial Litigation groups. Tim’s practice focuses on assisting clients navigate a range of antitrust issues from investigations and litigation to compliance with pre-merger CFIUS and HSR notification requirements. Additionally, Tim has experience representing leading technology, pharmaceutical, and financial services companies in complex commercial disputes throughout the United States.

Tim is a member of the firm’s Antitrust Technology Task Force and a frequent contributor to Proskauer’s Minding Your Business and Proskauer on Price Gouging blogs.

Tim also maintains an active pro bono practice, including representing asylum seekers pursuing claims against the United States for harm suffered in connection with the Trump Administration’s Family Separation Policy.

Tim earned his J.D. from Vanderbilt Law School, where he was the Executive Student Writing Editor for the Vanderbilt Journal of Transnational Law and interned at the U.S. Attorney’s Office for the Southern District of New York.

Prior to his legal career, Tim was a Teach For America corps member and taught elementary school in the Brownsville neighborhood of Brooklyn.